WELLBUTRIN XL
- Product NDC
- 21695-137
- 11-digit product format
- 216950137
- Labeler code
- 21695
- Product ID
- 21695-137_fdd1fa5e-9dbf-4951-a8e9-33d06e05bdba
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- NDA021515
- Marketing category
- NDA
- Marketing start
- 2009-12-23
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 21695-137-15 | WELLBUTRIN XL | 15 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 15 | | 1 |
| 21695-137-30 | WELLBUTRIN XL | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 1 |
| 21695-137-45 | WELLBUTRIN XL | 45 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 45 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| bupropion hydrochloride | ACTIVE INGREDIENT | ZG7E5POY8O | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| bupropion | ACTIVE MOIETY | 01ZG3TPX31 | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| ETHYLCELLULOSES | INACTIVE INGREDIENT | 7Z8S9VYZ4B | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| glyceryl behenate | INACTIVE INGREDIENT | R8WTH25YS2 | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| methacrylic acid - ethyl acrylate copolymer (1:1) type a | INACTIVE INGREDIENT | NX76LV5T8J | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| polyethylene glycol | INACTIVE INGREDIENT | 3WJQ0SDW1A | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| polyvinyl alcohol | INACTIVE INGREDIENT | 532B59J990 | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| povidone | INACTIVE INGREDIENT | FZ989GH94E | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
| triethyl citrate | INACTIVE INGREDIENT | 8Z96QXD6UM | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21695-137 | WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 1 | Legacy NDC, 3 package rows | 20110622_fdd1fa5e-9dbf-4951-a8e9-33d06e05bdba.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 21695-137-15 | 21695013715 | 15 in 1 BOTTLE | Historical |
| 21695-137-30 | 21695013730 | 30 in 1 BOTTLE | Historical |
| 21695-137-45 | 21695013745 | 45 in 1 BOTTLE | Historical |